Status: No longer developing NGS platform
Back in 2008 Affymetrix stated that they would start developing a chip combining DNA capture and enzymatic-based sequencing. While it is unclear how far along this technology was developed, Affymetrix has never released such a product and has since stated that they are not going to directly enter the next-generation sequencing market.
Please contact us at kb@allseq.com if you have any information or opinions you’d like to share about this page.